As of March 2024 Recro Pharma has a market cap of $0.12 Billion. This makes Recro Pharma the world's 7299th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $0.12 B | 54.6% |
2021 | $79.71 M | 18.29% |
2020 | $67.38 M | -84.23% |
2019 | $0.42 B | 176.09% |
2018 | $0.15 B | -12.52% |
2017 | $0.17 B | 16.31% |
2016 | $0.15 B | 83.23% |
2015 | $83.01 M | 276.61% |
2014 | $22.04 M |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $382.31 B | 310,134.00% | ๐บ๐ธ USA |
Pacira Biosciences
PCRX | $1.37 B | 1,012.40% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | $0.45 B | 272.41% | ๐บ๐ธ USA |
AcelRx Pharmaceuticals
ACRX | $14.57 M | -88.17% | ๐บ๐ธ USA |
Cara Therapeutics
CARA | $48.58 M | -60.57% | ๐บ๐ธ USA |